MedRecall

The MEDRECALL Method offers a proactive post-market surveillance solution that analyzes FDA adverse-event reports to rank medical device portfolios based on recall risk and early warning signals. Its main features include continuous ingestion of over 17 million adverse-event reports, dynamic re-ranking of devices with predictive risk scores, and detailed signal metrics such as injury severity, manufacturer history, and velocity trends, enabling quality assurance and regulatory teams to identify potential safety concerns months before official recall announcements. Designed for regulatory professionals, device manufacturers, and quality assurance teams, this tool addresses the challenge of delayed recall detection by providing forward-looking risk assessments that facilitate preemptive action and targeted post-market reviews.

MedRecall kan findes i Reputation Management & Review Monitoring kategorier.